PDS Biotechnology Corp
PDSB· Nasdaq
PDSBPDS Biotechnology Corp
Filed Nov 13, 2020 · 10-Q · 44 days after period end · 0001140361-20-025429
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Net Income | -$3.91M | -$5.75M | -$711.21K | -$11.28M |
| EPS Diluted | -$0.21 | -$1.10 | -$0.21 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 13, 2020 · 44 d after period end
